These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1480290)

  • 61. Inadvertent intrauterine infusion of ampicillin-sulbactam.
    Sigg TR; Kuhn BR
    Am J Health Syst Pharm; 2000 Feb; 57(3):215. PubMed ID: 10674773
    [No Abstract]   [Full Text] [Related]  

  • 62. Randomized comparative study of ampicillin/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children.
    Kulhanjian J; Dunphy MG; Hamstra S; Levernier K; Rankin M; Petru A; Azimi P
    Pediatr Infect Dis J; 1989 Sep; 8(9):605-10. PubMed ID: 2677956
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The clinical diagnosis and treatment of ascending infections of the genitalia by using the combined preparation ampicillin/sulbactam (Unasyn)].
    Eibach HW
    Antibiot Khimioter; 1991 Jun; 36(6):13-5. PubMed ID: 1832852
    [No Abstract]   [Full Text] [Related]  

  • 64. Ampicillin/sulbactam versus cefotetan for the prevention of infection following cesarean delivery in high-risk patients: a randomized double-blind trial.
    Bracero LA
    Gynecol Obstet Invest; 1997; 44(1):21-5. PubMed ID: 9251949
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sulbactam in combination with mezlocillin, piperacillin or cefotaxime: clinical and bacteriological findings in the treatment of serious bacterial infections.
    Manncke K; Springsklee M; Heizmann WR; Sonntag HG
    Int J Antimicrob Agents; 1996 Apr; 6 Suppl():S47-54. PubMed ID: 18611720
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sulbactam/ampicillin followed by oral treatment with sultamicillin for medical and surgical infections.
    Chang ST; Chung HY; Pai SD; Lee JH
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):175S-178S. PubMed ID: 2686917
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antibiotic prophylaxis in head and neck oncologic surgery: the role of gram-negative coverage.
    Callender DL
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S21-5; discussion S26-7. PubMed ID: 10526870
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and cost of ampicillin-sulbactam and ticarcillin-clavulanate in the treatment of hospitalized patients with bacterial infections.
    McKinnon PS; Neuhauser MM
    Pharmacotherapy; 1999 Jun; 19(6):724-33. PubMed ID: 10391418
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Experience with ampicillin/sulbactam in severe infections.
    Kanra G
    J Int Med Res; 2002; 30 Suppl 1():20A-30A. PubMed ID: 11921491
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sulbactam/ampicillin versus cefotaxime as initial therapy in serious soft tissue, joint and bone infections.
    Löffler L; Bauernfeind A; Keyl W
    Drugs; 1988; 35 Suppl 7():46-52. PubMed ID: 3265378
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Randomised study of prophylactic parenteral sulbactam/ampicillin and cephazolin in biliary surgery: significant benefit in jaundiced patients.
    Morris DL; Jones JA; Harrison JD; Andrews GI; Phillips RJ; Slack RC
    J Hosp Infect; 1989 Apr; 13(3):261-6. PubMed ID: 2567755
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical evaluation of sulbactam/ampicillin in Japan.
    Shimada K
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):171S-174S. PubMed ID: 2686916
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A bacteriological assessment of ampicillin with sulbactam as antibiotic prophylaxis in patients undergoing biliary tract operations. The West of Scotland Surgical Infection Study Group.
    Edwards GF; Lindsay G; Taylor EW
    J Hosp Infect; 1990 Oct; 16(3):249-55. PubMed ID: 1979575
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Clinical aspects of the pharmacokinetics of unasyn (an ampicillin-sulbactam combination].
    Kozyrev VN
    Antibiot Khimioter; 1992 Oct; 37(10):46-51. PubMed ID: 1296537
    [No Abstract]   [Full Text] [Related]  

  • 75. [Unasyn in perioperative prophylaxis in patients with laryngeal cancer].
    Szmeja Z; Szyfter W; Manasterski J
    Otolaryngol Pol; 1994; 48(3):275-8. PubMed ID: 8090491
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patients.
    Kaye KS; Harris AD; Gold H; Carmeli Y
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1004-9. PubMed ID: 10722504
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of intracranial abscesses: experience with sulbactam/ampicillin.
    Akova M; Akalìn HE; Korten V; Ozgen T; Erbengi A
    J Chemother; 1993 Jun; 5(3):181-5. PubMed ID: 8371128
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess.
    Allewelt M; Schüler P; Bölcskei PL; Mauch H; Lode H;
    Clin Microbiol Infect; 2004 Feb; 10(2):163-70. PubMed ID: 14759242
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetics of ampicillin, sulbactam and cefotiam in patients undergoing orthopedic surgery.
    Wildfeuer A; Mallwitz J; Gotthardt H; Hille E; Gruber H; Dahmen G; Pfaff G; Göbel C
    Infection; 1997; 25(4):258-62. PubMed ID: 9266270
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sulbactam/ampicillin in the treatment of pediatric infections.
    Kanra G; Secmeer G; Akalin E; Ecevit Z; Calikoglu AS; Gunel M; Tarim O
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):185S-187S. PubMed ID: 2591177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.